044960 — Eagle Veterinary Technology Co Balance Sheet
0.000.00%
- KR₩53bn
- KR₩53bn
- KR₩42bn
- 83
- 45
- 11
- 43
Annual balance sheet for Eagle Veterinary Technology Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | — | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,194 | 8,826 | 5,389 | 6,092 | 7,200 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,354 | 7,367 | 8,380 | 8,908 | 9,586 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23,200 | 26,716 | 26,242 | 26,350 | 28,070 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 19,663 | 19,062 | 19,482 | 23,867 | 24,518 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 48,408 | 52,601 | 54,866 | 58,479 | 61,237 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,456 | 8,328 | 8,207 | 9,845 | 10,073 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 10,673 | 11,771 | 11,912 | 13,136 | 12,647 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Total Equity | 37,735 | 40,830 | 42,954 | 45,343 | 48,590 |
Total Liabilities & Shareholders' Equity | 48,408 | 52,601 | 54,866 | 58,479 | 61,237 |
Total Common Shares Outstanding |